The CEO's unplanned open-market sale of $275K is the most informative element — no 10b5-1 plan indicated, suggesting a potential negative catalyst ahead. Monitor for upcoming clinical trial data readouts or financing announcements that could explain the timing.
Price Chart
Executive Summary
CEO Lin Shao-Lee and VP Meluzio Michael Vincent sold a combined $307K in open-market sales on October 12, 2026. The CEO's $275K sale is the dominant transaction, representing a modest but notable insider sale for a small-cap biotech. The cluster is entirely open-market selling with no 10b5-1 plan indication, which is a bearish signal, though the dollar amount is modest relative to the company's market cap.
Key Financial Metrics
Key Facts
- CEO Lin Shao-Lee sold 10,000 shares at $27.50 for $275,000 on October 12, 2026
- VP Meluzio Michael Vincent sold 1,087 shares at $28.05 for $30,490 on October 12, 2026
- Total open-market sales: $307,490, all on the same day
- No 10b5-1 plan indication for either sale
- Cluster is 100% selling with no offsetting insider purchases
Financial Impact
$307,490 in insider open-market sales, all by C-suite officer
Risk Factors
- CEO selling without a trading plan may signal adverse clinical or operational developments
- Small absolute dollar amount ($307K) may be routine diversification, not a material signal
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-CUE-1792028324775 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 14, 2026 11d ago | Insider Cluster | $18.67 $16.71 | ▲ +10.50% | ▲ +9.39% | $18.45 (+1.18%) |
Oct 13, 2026 12d ago | 144 | $18.60 $18.67 | ▲ +0.38% | ▲ +0.09% | $18.45 (−0.81%) |
Oct 8, 2026 18d ago | SC 13G/A | $22.33 $27.66 | ▲ +23.87% | ▲ +23.27% | $18.45 (−17.38%) |
Sep 21, 2026 5w ago | 8-K | $28.27 $30.90 | ▲ +9.30% | ▲ +9.32% | $18.45 (−34.74%) |
Sep 20, 2026 5w ago | Press Release | $28.27 $30.90 | ▲ +9.30% | ▲ +9.32% | $18.45 (−34.74%) |
Aug 21, 2026 9w ago | EFFECT | $23.98 $23.18 | ▲ +3.34% | ▲ +3.04% | $18.45 (+23.06%) |
Aug 17, 2026 9w ago | Insider Cluster | $25.70 $26.28 | ▼ −2.26% | ▼ −2.05% | $18.45 (+28.21%) |
Aug 14, 2026 10w ago | Press Release | $27.64 $25.70 | ▼ −7.02% | ▼ −6.34% | $18.45 (−33.25%) |
Aug 13, 2026 10w ago | 144 | $34.20 $27.64 | ▼ −19.18% | ▼ −18.71% | $18.45 (−46.05%) |
Jul 9, 2026 15w ago | Press Release | $36.78 $30.92 | ▼ −15.93% | ▼ −15.17% | $18.45 (−49.84%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers